| Nolan JC, Frawley T, Tighe J, Soh H, Curtin C, Piskareva O, 2020 Jan 18, Preclinical models for neuroblastoma: Advances and challenges. Cancer Lett, DOI: 10.1016/j.canlet.2020.01.015 |
| Piacenti V, Langella E, Autiero I, Nolan JC, Piskareva O, Adamo MFA, Saviano M, Moccia M, 2019 Oct, A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a. Bioorg Chem, DOI: 10.1016/j.bioorg.2019.103165 |
| Soriano A, Masanas M, Boloix A, Masiá N, París-Coderch L, Piskareva O, Jiménez C, Henrich KO, Roma J, Westermann F, Stallings RL, Sábado C, de Toledo JS, Santamaria A, Gallego S, Segura MF, 2019 Jun, Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma. Cell Mol Life Sci, DOI: 10.1007/s00018-019-03041-4 |
| Monopoli MP, Zendrini A, Wu D, Cheung S, Sampedro G, Ffrench B, Nolan J, Piskareva O, Stalings RL, Ducoli S, Bergese P, O'Shea DF, 2018 Jun 26, Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe. Chem Commun (Camb), DOI: 10.1039/c8cc02135j |
| Curtin C, Nolan JC, Conlon R, Deneweth L, Gallagher C, Tan YJ, Cavanagh BL, Asraf AZ, Harvey H, Miller-Delaney S, Shohet J, Bray I, O'Brien FJ, Stallings RL, Piskareva O, 2018 Apr 1, A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models. Acta Biomater, DOI: 10.1016/j.actbio.2018.02.004 |
| Smith S, Fernando T, Wu PW, Seo J, Ní Gabhann J, Piskareva O, McCarthy E, Howard D, O'Connell P, Conway R, Gallagher P, Molloy E, Stallings RL, Kearns G, Forbess L, Ishimori M, Venuturupalli S, Wallace D, Weisman M, Jefferies CA, 2017 May, MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE. J Autoimmun, DOI: 10.1016/j.jaut.2017.03.003 |
| Nolan J, Stallings RL, Piskareva O, 2017, Assessment of Basic Biological Functions Exerted by miRNAs. Methods Mol Biol, DOI: 10.1007/978-1-4939-6524-3_2 |
| Soriano A, París-Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, Bray I, Vidal I, Almazán-Moga A, Molist C, Roma J, Bayascas JR, Casanovas O, Stallings RL, Sánchez de Toledo J, Gallego S, Segura MF, 2016 Feb 23, MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget, DOI: 10.18632/oncotarget.7005 |
| Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P, Dowling P, Henry M, O'Sullivan F, Bray I, Stallings RL, 2015 Aug 10, The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Lett, DOI: 10.1016/j.canlet.2015.05.004 |
| Harvey H, Piskareva O, Creevey L, Alcock LC, Buckley PG, O'Sullivan MJ, Segura MF, Gallego S, Stallings RL, Bray IM, 2015 Apr 1, Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f. Int J Cancer, DOI: 10.1002/ijc.29144 |
| Piskareva O, Ernst C, Higgins N, Schmatchenko V, 2013, The carboxy-terminal segment of the human LINE-1 ORF2 protein is involved in RNA binding. FEBS Open Bio, DOI: 10.1016/j.fob.2013.09.005 |
| Domingo-Fernandez R, Watters K, Piskareva O, Stallings RL, Bray I, 2013 Feb, The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis. Pediatr Surg Int, DOI: 10.1007/s00383-012-3239-7 |
| Das S, Bryan K, Buckley PG, Piskareva O, Bray IM, Foley N, Ryan J, Lynch J, Creevey L, Fay J, Prenter S, Koster J, van Sluis P, Versteeg R, Eggert A, Schulte JH, Schramm A, Mestdagh P, Vandesompele J, Speleman F, Stallings RL, 2013 Jun 13, Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene, DOI: 10.1038/onc.2012.311 |
| Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, Piskareva O, Ng CY, Lode HN, Davidoff AM, Stallings RL, 2012, Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS One, DOI: 10.1371/journal.pone.0038129 |
| Piskareva O, Lackington W, Lemass D, Hendrick C, Doolan P, Barron N, 2011 Jun, The human L1 element: a potential biomarker in cancer prognosis, current status and future directions. Curr Mol Med, DOI: 10.2174/156652411795677954 |
| Piskareva O, Clynes M, Barron N, 2007 Apr, Detection and cloning of LINE-1 elements in CHO cells. Cytotechnology, DOI: 10.1007/s10616-007-9051-x |
| Barron N, Piskareva O, Muniyappa M, 2007 Apr, Targeted genetic modification of cell lines for recombinant protein production. Cytotechnology, DOI: 10.1007/s10616-007-9050-y |
| Piskareva O, Clynes M, Barron N, 2007 May, Detection and cloning of LINE-1 elements in CHO cells. Cytotechnology, DOI: 10.1007/s10616-007-9068-1 |
| Piskareva O, Schmatchenko V, 2006 Jan 23, DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template in vitro. FEBS Lett, DOI: 10.1016/j.febslet.2005.12.077 |
| Piskareva OA, Barron N, Clynes M, Shmatchenko VV, 2004 Mar-Apr, In vivo cytoplasmic localization of the p40 protein of the L1 transposable element of human genome. Dokl Biochem Biophys, DOI: 10.1023/b:dobi.0000025561.05664.c1 |
| Piskareva O, Denmukhametova S, Schmatchenko V, 2003 Mar, Functional reverse transcriptase encoded by the human LINE-1 from baculovirus-infected insect cells. Protein Expr Purif, DOI: 10.1016/s1046-5928(02)00655-1 |
| Piskareva OA, Rochev IuA, Gavriliuk BK, Gorelov AV, Golubeva TA, Dawson KA, 1999 Mar-Apr, [Effect of thermoreverse polymer matrix and collagen on the growth of human fibroblasts]. Biofizika, DOI: 10.1016/s1046-5928(02)00655-1 |
